APA (7th ed.) Citation

D, W., M, B., A, K., C, K., M, D., J, W., . . . A, J. (2025). 17.6% of patients in a German cohort with exocrine pancreatic cancer were diagnosed with a genetic tumor syndrome-a case for universal genetic testing? ESMO gastrointestinal oncology, 9, 100218. https://doi.org/10.1016/j.esmogo.2025.100218

Chicago Style (17th ed.) Citation

D, William, et al. "17.6% of Patients in a German Cohort with Exocrine Pancreatic Cancer Were Diagnosed with a Genetic Tumor Syndrome-a Case for Universal Genetic Testing?" ESMO Gastrointestinal Oncology 9 (2025): 100218. https://doi.org/10.1016/j.esmogo.2025.100218.

MLA (9th ed.) Citation

D, William, et al. "17.6% of Patients in a German Cohort with Exocrine Pancreatic Cancer Were Diagnosed with a Genetic Tumor Syndrome-a Case for Universal Genetic Testing?" ESMO Gastrointestinal Oncology, vol. 9, 2025, p. 100218, https://doi.org/10.1016/j.esmogo.2025.100218.